Kumari M, Rathi B, Singh G. Epicatechin as a potential hit to target ERK2 in breast cancer: molecular docking, molecular dynamic simulation studies. J Integr Sci Technol [Internet]. 2025 Jan. 16 [cited 2025 Jun. 26];13(4):1074. Available from: https://pubs.thesciencein.org/journal/index.php/jist/article/view/a1074